309
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Synthesis and in vitro anticancer activities of biotinylated derivatives of glaucocalyxin A and oridonin

, , , , , , , , , , & show all
Pages 703-711 | Received 09 Jan 2020, Accepted 22 Apr 2020, Published online: 22 May 2020
 

Abstract

Fourteen glaucocalyxin A biotinylated derivatives, one glaucocalyxin C biotinylated derivative, and two oridonin biotinylated derivatives were designed and synthesized. Their structures were confirmed from 1H NMR, 13C NMR and HRMS data. The derivatives were evaluated for cytotoxic activities against lung (A549), cervical cancer cell line HeLa derivative (KB), multidrug-resistant KB subline (KB-VIN), triple-negative breast (MDA-MB-231), and estrogen receptor-positive breast (MCF-7) cancer cell lines.

Graphical Abstract

Disclosure statement

No potential conflict of interest was reported by the author(s).

Additional information

Funding

This study was funded by the National Natural Science Foundation of China (grant number 81202882); the Social Development Project in Jiangsu Province of China (grant number BE2018322); the Priority Academic Program Development of the Jiangsu Higher Education Institutes, China (PAPD). Partial support was received from National Institutes of Health, NIH (grant number CA177584) awarded to Kuo-Hsiung Lee.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.